Open AccessEarly Visual Functional Outcomes and Morphological Responses to Anti-Vascular Growth Factor Therapy in Diabetic Macular Oedema Using Optical Coherence Tomography Angiography
Author(s) -
Supriya Dabir,
Mohan Rajan,
Liji Parasseril,
Vaidehi Bhatt,
Preetam Samant,
C. A. B. Webers,
Tos T. J. M. Berendschot
Publication year - 2021
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s285388
Subject(s) - medicine , ophthalmology , ranibizumab , diabetic retinopathy , retinal , perfusion , visual acuity , optical coherence tomography , optical coherence tomography angiography , angiography , fluorescein angiography , diabetes mellitus , bevacizumab , surgery , radiology , chemotherapy , endocrinology
Diabetic macular oedema (DME) is a vision-threatening complication of diabetic retinopathy. Spectral domain optical coherence tomography angiography (OCTA) is useful for assessing DME. We performed serial OCTA measurements before and after 3 monthly intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections to understand its relationship with best corrected visual acuity (BCVA), central macular thickness (CMT) and vascular indices.